Clinical Characteristics and Prognosis of Elderly Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy Only

Yingchen Lyu,Mengdong Ni,Rui Zhai,Fanliang Kong,Chengrun Du,Chaosu Hu,Ying Hong-mei

DOI: https://doi.org/10.1016/j.ijrobp.2020.07.366

2020-01-01

Abstract:In this study, we aim to evaluate the clinical characteristics and prognosis of elderly nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) only. From June 2008 to October 2014, 89 newly diagnosed non-metastatic elderly NPC patients (aged ≥70 years) receiving IMRT without chemotherapy were recruited at one institution. Comorbid condition was evaluated using the age-adjusted Charlson Comorbidity Index (ACCI). Kaplan-Meier method was used to estimate survival rates and the differences were compared using log-rank test. Hazard ratio (HR) and the associated 95% confidence interval (CI) were calculated using Cox proportional hazard model by means of multivariate analyzing. The comorbidity level was scored according to the age-adjusted Charlson Comorbidity Index (ACCI). The score was 0 in 60 (67.42%), 1 in 21(23.6%), 2 in 5(5.62%), 3 in 2 (2.25%) and 10 in 1(1.12%). Severe acute mucositis and dermatitis (grade 3 or 4) occurred in 24.72% and 5.62% respectively. Emesis occurred in 11.2% of patients without grade 3 or 4 events. For hematologic adverse events, incidence of grade 3 leukopenia was 1.12%, which was the same with incidence of grade 3 neutrocytopenia and thrombocytopenia. No grade 4 hematologic toxicity was observed. The median follow-up time was 98.43 months (95% CI:87.47 to 103.17 months). Estimated OS rate at 5 years for the entire group was 58.4% (95% CI, 0.475 to 0.679). A 5-year OS rate of 63.0% was observed in patients younger than 75 years old compared with 51.4% in patients older (p = 0.0319). Patients with early stage disease (stage Ⅰ to Ⅱ) showed better prognosis than patients with advanced stage disease (stage Ⅲ to Ⅳ) (5-year OS,73.8% to 44.7%, respectively; p = 0.0002). ACCI score equal to or less than 3 was associated with superior 5-year OS rate in comparison with higher ACCI score (65.0% to 46.9%, respectively; p = 0.005). The Cox proportional hazards model suggested that ACCI score more than 3 independently predicted poorer OS (HR,1.93;95% CI,1.06-3.53). The survival outcome of patients aged ≥70 years is acceptable with a manageable toxicity with IMRT only. Among this population, ACCI score was significantly prognostic for survival outcome. Further investigation is urgently needed to fully assess the elderly individuals and personalize treatment strategy.